Insulin pen use for type 2 diabetes--a clinical perspective.
While insulin delivery technology continues to progress, its adoption in the clinic lags behind, particularly in people with type 2 diabetes. In this article the authors present their clinical perspective regarding insulin pen therapy in this population.
Bailey
Timothy S
TS
AMCR Institute, 700 West El Norte Parkway, Escondido, CA 92026, USA. tbailey@amcrinstitute.com
Edelman
Steven V
SV
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000523:psychology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000523:psychology; D004867:Equipment Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D040541:Marketing / Q000379:methods; D009339:Needles; D010465:Perception
D007004:Hypoglycemic Agents; D007328:Insulin